Buy Day today: Neutral (57) Mixed market breadth · major macro event coming up

Agilent Technologies Inc

Healthcare · Diagnostics & Research

166.70$ -3.3% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Income Statement

Agilent Technologies Inc (A) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,878 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement A
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	1,111	1,067	1,102	1,114	1,189	1,211	1,206	1,203	1,294	1,284	1,238	1,274	1,367	1,357	1,238	1,261	1,483	1,548	1,525	1,586	1,660	1,674	1,607	1,718	1,849	1,756	1,717	1,672	1,688	1,658	1,573	1,578	1,701	1,681	1,668	1,738	1,861	1,798	1,835	1,878	7,372
Cost of Revenue	523	493	510	518	542	538	562	542	585	577	569	582	630	634	581	592	695	710	708	734	760	764	746	779	837	788	793	1,014	773	750	717	723	785	782	802	824	897	852	826	836	3,411
Gross Profit	588	574	592	596	647	673	644	661	709	707	669	692	737	723	657	669	788	838	817	852	900	910	861	939	1,012	968	924	658	915	908	856	855	916	899	866	914	964	946	1,009	1,042	3,961
Research & Development	84	79	84	87	89	93	91	97	104	102	99	101	102	104	197	92	102	103	109	113	116	117	115	116	119	123	126	118	114	128	113	127	111	113	112	111	119	117	126	123	485
Selling, General & Administrative	321	289	307	308	325	341	338	339	356	355	354	366	385	404	358	347	387	407	420	403	389	417	386	412	422	419	415	407	593	396	380	395	361	410	454	417	428	476	465	475	1,844
Total Operating Expenses	405	368	391	395	414	441	433	436	460	457	453	467	487	508	555	439	489	510	529	516	505	534	501	528	541	542	541	525	507	524	493	522	508	523	566	554	521	593	610	598	2,322
Operating Income	183	206	201	201	233	229	210	216	244	250	216	225	250	215	102	230	299	328	288	336	395	376	360	411	471	426	383	133	408	384	363	333	408	376	300	360	443	353	399	444	1,639
Interest Expense	19	20	20	19	20	20	19	18	18	18	17	18	21	20	20	19	19	19	20	21	21	21	21	19	23	25	24	24	22	22	20	22	32	28	29	28	27	25	25	29	106
Pre-Tax Income	151	193	191	193	226	233	227	242	244	248	218	222	231	219	121	219	283	312	273	327	448	319	333	397	455	410	377	132	420	403	374	343	401	367	260	366	442	364	408	444	1,658
Income Tax Expense	25	25	27	18	49	553	22	6.0	49	-256	36	31	37	22	20	20	61	24	57	63	6.0	36	59	68	87	58	75	21	-55	55	66	61	50	49	45	30	8.0	59	69	82	218
Net Income	124	168	164	175	177	-320	205	236	195	504	182	191	194	197	101	199	222	288	216	264	442	283	274	329	368	352	302	111	475	348	308	282	351	318	215	336	434	305	339	362	1,440
EBITDA	226	268	265	263	298	304	296	313	318	320	288	295	328	318	217	315	378	407	370	432	553	422	436	497	551	502	472	227	504	487	436	428	502	467	362	466	540	456	500	473	1,969

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings